Biopharma | January 23, 2026
Alteogen strikes $285M deal with GSK subsidiary for innovative cancer drug delivery
This deal marks a major step for Alteogen as it pushes its Hybrozyme platform deeper into the oncology market
This deal marks a major step for Alteogen as it pushes its Hybrozyme platform deeper into the oncology market
Feldan's proprietary Shuttle peptide technology enables the efficient and targeted delivery of biomolecules into cells, unlocking new therapeutic possibilities
Nanomi's pioneering approach in drug delivery has set new benchmarks in the industry, and this award serves as a motivation to continue its mission to revolutionize healthcare
More than 10,000 scientific publications containing EUDRAGIT
Three block copolymers added to RESOMER portfolio of bioabsorbable polymers
The VitalDose Drug Delivery Platform has been used in patient-centric dose forms in women’s health for over two decades
Collaboration combines clinical research expertise with artificial intelligence capabilities to help drug developers better understand the probability of clinical success for their assets
The increased drug load enabled by the nanoformed particles also allows smaller implants with sustained release properties to be developed.
Nearly 5000 executives and more than 350 exhibitors turned out at the largest post-pandemic pharma packaging event
Availability of pharmaceutical-grade materials with broad API compatibility key to advancing drug delivery solutions
Subscribe To Our Newsletter & Stay Updated
